Test Price
4,000 AED✅ Home Collection Available
Cultured AFB Antitubercular DST Rapid 19-Drug Panel in UAE | 4,000 AED
Executive Summary & Core Metrics
This test determines the susceptibility profile of cultured Mycobacterium tuberculosis complex to 19 first- and second-line antitubercular drugs, enabling precision therapy selection and resistance surveillance. Our laboratory is ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139). For this specific test, sample collection must be performed at an accredited healthcare facility – mobile home phlebotomy is not available. We provide telephone clinical guidance post-results and direct insurance verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This advanced panel rapidly quantifies drug susceptibility of cultured TB isolates to 19 agents, including rifampicin, isoniazid, fluoroquinolones, and injectables, using an automated fluorescent detection system with LC-MS/MS‑grade precision. Results are standardized for clinical decision‑making and drug resistance monitoring.
| Feature | Our Test | Closest Alternative |
|---|---|---|
| Precision | 99.9% diagnostic sensitivity with automated fluorescent detection | Manual proportion method, higher variability |
| Method | Automated Fluorescent (LC‑MS/MS‑grade accuracy) | Conventional agar proportion |
| Speed | Standardised 21‑day reporting from pure isolate | Often 28–42 days |
| Certification | ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) | May lack ISO‑accredited DST |
Physician Insight & Safety Protocols
“Drug susceptibility reports must be integrated with the patient’s clinical picture, radiographic imaging, and therapeutic history. Even when a drug appears sensitive, absorption, adherence, and drug‑drug interactions can influence outcomes. I strongly recommend a multidisciplinary review before altering any regimen.”
— Dr. Ajay Singh, General Practitioner, DHA License 36234132
Patient Safety Advisory
Do not discontinue or modify any prescribed anti‑TB medication based solely on this test result without explicit advice from your treating physician. Always consult your doctor before making treatment changes.
Exclusion Criteria & Emergency Red Flags
- Contaminated specimen, non‑viable culture, or mixed bacterial growth will lead to test rejection.
- If you experience severe haemoptysis, sudden shortness of breath, intense chest pain, or altered consciousness, seek emergency care immediately.
Patient FAQ & Clinical Guidance
1. What does the Cultured AFB DST Rapid 19‑Drug Panel detect?
It precisely measures the susceptibility of cultured tuberculosis bacteria to 19 antitubercular drugs, guiding clinicians to select the most effective and least toxic therapy.
2. How long does it take to receive results?
Laboratory reports are issued within 21 calendar days after receipt of a pure, viable isolate, processed via automated fluorescent technology for rapid readout.
3. Is home collection available for this test?
No. This test requires a pure culture isolate obtained from a clinical specimen (e.g., sputum) that must be collected under controlled conditions at an accredited hospital or clinic. Mobile home phlebotomy is not suitable for this test.
4. What are the risks or limitations?
The panel may not cover all possible drug resistances. Results should be interpreted alongside clinical history, imaging, and previous therapy. Contaminated or non‑viable cultures may delay results or require repeat sampling.
UAE Regulatory & Data Privacy Adherence
This test is performed under the regulatory oversight of the Dubai Health Authority (DHA). All personal data is handled in strict compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. Your results and personal information are securely encrypted and accessible only to authorized healthcare providers.
Clinical & Logistical Metadata
| Test Name | Cultured AFB Antitubercular DST Rapid 19-Drug Panel |
| Price (AED) | 4,000 |
| Turnaround Time | 21 calendar days |
| Sample Type / Matrix | Cultured Mycobacterium tuberculosis isolate (Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety.) |
| Methodology Used | Automated Fluorescent Detection (LC-MS/MS-grade accuracy) |
| ICD-10-CM Code | Z01.89 |
| LOINC Code | 101468-0 |
| DHA Facility License & Lab Address | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians